We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$14.7B
AUM Growth
-$2.91B
Cap. Flow
-$2.63B
Cap. Flow %
-17.88%
Top 10 Hldgs %
6.52%
Holding
4,319
New
695
Increased
988
Reduced
1,077
Closed
1,450

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$66.2M
2
WFC icon
Wells Fargo
WFC
+$57M
3
SNOW icon
Snowflake
SNOW
+$53.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$52.1M
5
AVGO icon
Broadcom
AVGO
+$43.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$76.6M
2
ZTS icon
Zoetis
ZTS
+$67.5M
3
UBER icon
Uber
UBER
+$57.3M
4
MMM icon
3M
MMM
+$53.2M
5
NFLX icon
Netflix
NFLX
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Industrials 6.11%
3 Consumer Discretionary 5.41%
4 Financials 4.9%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKG icon
2951
ARK Genomic Revolution ETF
ARKG
$1.79B
-19,061
Closed -$481K
ARKK icon
2952
ARK Innovation ETF
ARKK
$6.38B
-137,976
Closed -$6.16M
ARLO icon
2953
Arlo Technologies
ARLO
$1.59B
-488,621
Closed -$6.18M
ARMK icon
2954
Aramark
ARMK
$15.9B
-1,980
Closed -$64.3K
ARQT icon
2955
Arcutis Biotherapeutics
ARQT
$3.3B
-20,705
Closed -$205K
ARVN icon
2956
Arvinas
ARVN
$588M
-53,203
Closed -$2.2M
ARW icon
2957
Arrow Electronics
ARW
$10.5B
-18,884
Closed -$2.44M
ASLE icon
2958
AerSale
ASLE
$273M
-391
Closed -$2.81K
ASND icon
2959
Ascendis Pharma A/S
ASND
$16.7B
-33,661
Closed -$5.09M
ASTE icon
2960
Astec Industries
ASTE
$989M
-5,024
Closed -$220K
ASTS icon
2961
AST SpaceMobile
ASTS
$21.4B
-8,103
Closed -$42.4K
ATAI icon
2962
AtaiBeckley Inc
ATAI
$2.67B
-36,288
Closed -$71.5K
ATAT icon
2963
Atour Lifestyle Holdings
ATAT
$4.63B
-121,307
Closed -$2.18M
LONA
2964
LeonaBio Inc
LONA
$71.6M
-1,100
Closed -$30.1K
ATHM icon
2965
Autohome
ATHM
$2.65B
-81,100
Closed -$2.13M
ATKR icon
2966
CALL
Atkore
ATKR
$3.17B
-1,100
Closed -$209K
ATR icon
2967
AptarGroup
ATR
$8.57B
-28,679
Closed -$4.13M
ATRC icon
2968
AtriCure
ATRC
$2.18B
-152,931
Closed -$4.65M
OPTU
2969
Optimum Communications Inc
OPTU
$324M
-118,095
Closed -$308K
AU icon
2970
AngloGold Ashanti
AU
$49.3B
-11,558
Closed -$274K
AUDC icon
2971
AudioCodes
AUDC
$253M
-25,674
Closed -$335K
AUTL
2972
Autolus Therapeutics
AUTL
$620M
-160
Closed -$1.02K
AVAH icon
2973
Aveanna Healthcare
AVAH
$1.95B
-8,635
Closed -$21.5K
AVDL
2974
DELISTED
Avadel Pharmaceuticals
AVDL
-168,528
Closed -$2.85M
AVDX
2975
DELISTED
AvidXchange
AVDX
-439,405
Closed -$5.78M

Similar funds

Cubist Systematic Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Cubist Systematic Strategies held 4,319 positions worth $14.7B, down 17% from $17.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Cubist Systematic Strategies withdrew a net $2.63B in Q2 2024, closing 1,450 positions and reducing 1,077 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $76.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in General Motors worth $68.2M.

  • Cubist Systematic Strategies's largest Q2 2024 buy was General Motors: 1,467,209 shares worth $68.2M.
  • Cubist Systematic Strategies added most to Thermo Fisher Scientific in Q2 2024, an estimated $52.1M increase.
  • Cubist Systematic Strategies's biggest Q2 2024 reduction was Uber, cutting an estimated $57.3M.
  • Cubist Systematic Strategies fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $76.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.5% of its $14.7B portfolio in Q2 2024.
  • Cubist Systematic Strategies opened 695 new positions and closed 1,450 in Q2 2024.
  • Cubist Systematic Strategies's portfolio value fell 17% quarter-over-quarter to $14.7B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.